Literature DB >> 28025684

Utility of anterior vaginal wall length measurement in vaginal reconstructive surgery.

Amy F Collins1, Paula J Doyle1, Smitha Vilasagar1, Gunhilde M Buchsbaum2.   

Abstract

INTRODUCTION AND HYPOTHESIS: The pelvic organ prolapse quantification system (POP-Q) is the most commonly used method to quantify the extent of pelvic organ prolapse. However, it does not include assessment of anterior vaginal wall length (AVL). The objectives of this study were to characterize AVL and distance to the sacrospinous ligament (SSL), and to examine associations between total vaginal length (TVL), AVL, body mass index (BMI) and age.
METHODS: This was a retrospective chart review of 139 patients with cervix in situ presenting during an 8-month period for initial evaluation to the University of Rochester Medical Center Urogynecology practice. AVL, TVL and distance to the SSL were measured in addition to POP-Q measurements. Age, height, BMI, presenting complaint and prolapse stage were obtained from medical records. Simple linear regression was used to assess the relationship between TVL and AVL. Multivariate regression was used to test independent variables.
RESULTS: The mean ± SD TVL, AVL and distance to the SSL were 9.4 ± 1.2 cm, 7.4 ± 0.9 cm and 7.2 ± 0.9 cm, respectively. All three measurements approached a normal distribution. TVL decreased slightly with age. No association was found between vaginal length and BMI or parity.
CONCLUSIONS: AVL is a useful measurement that may aid in surgical decision-making. Providers should consider using AVL when planning sacrospinous hysteropexy.

Entities:  

Keywords:  Anterior vaginal wall; Hysteropexy; Pelvic organ prolapse quantification; Vaginal length

Mesh:

Year:  2016        PMID: 28025684     DOI: 10.1007/s00192-016-3247-6

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  1 in total

1.  Total vaginal length: Does it matter for assessing uterine prolapse?

Authors:  Myriam Girgis; Ka Lai Shek; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2018-10-24       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.